Combination Therapy

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

The latest EMBER-3 readout points to meaningful delays before chemotherapy for patients progressing after aromatase inhibitors.